11 companies, privately held.
Cambrian Bio
Longevity · A group of companies developing drugs aimed at ageing biology
Latest (Jul 15, 2026): Cambrian Bio reports $123.8 million of equity sold in a private offering
Open profile →Life Biosciences
Longevity · Partial epigenetic reprogramming
Latest (Apr 24, 2026): Life Biosciences reports $31 million of equity sold in a private offering
Open profile →Neuralink
Neurotechnology & BCI · Implanted brain-computer interface
Latest (Jun 12, 2025): Neuralink reports $649 million of equity sold in a private offering
Open profile →NewLimit
Longevity · Epigenetic reprogramming
Latest (May 15, 2025): NewLimit reports $129.8 million of equity sold in a private offering
Open profile →Precision Neuroscience
Neurotechnology & BCI · Thin-film brain-computer interface
Latest (Sep 28, 2026): Precision Neuroscience reports $250 million of securities sold in a private offering
Open profile →Rejuvenate Bio
Longevity · Gene & cell engineering · Gene therapy for ageing-related disease
Latest (Jun 18, 2026): Rejuvenate Bio reports $19.5 million of equity sold in a private offering
Open profile →Science Corp.
Neurotechnology & BCI · Physical augmentation · Neural engineering, including a retinal prosthesis
Latest (Mar 6, 2026): Science Corp. reports $230 million of securities sold in a private offering
Open profile →Colossal Biosciences
Synthetic biology · Genetic engineering, including de-extinction projects
No developments in the current window yet.
Open profile →Loyal (Cellular Longevity)
Longevity · Lifespan-extension drugs for dogs
No developments in the current window yet.
Open profile →Paradromics
Neurotechnology & BCI · High-data-rate brain-computer interface
No developments in the current window yet.
Open profile →Synchron
Neurotechnology & BCI · Brain-computer interface implanted through blood vessels
No developments in the current window yet.
Open profile →Coverage is not an offer to invest. Private ownership does not imply available shares. Sector labels are Sapien Frontier’s own coverage classification, not company claims.
Missing a company? Request future coverage. We add a company when its filings, offering notices or awards can be followed reliably. See what we cover and how often.